Hepatitis B — Nigeria

High prevalence, a birth dose in policy, and coverage that collapses outside health facilities.

Illustration: Hepatitis B — Nigeria

The legal framework

Nigeria has one of the larger burdens of chronic hepatitis B in the world. The birth dose is part of national policy, but a large share of births take place outside health facilities, and birth dose coverage is consequently far below the coverage of later doses. Treatment is available but generally paid for by the patient, which is the principal barrier.

Nigeria has hepatitis B in its routine immunisation schedule with a birth dose, but timely coverage is low: many births occur outside facilities, and even institutional deliveries often miss the twenty-four hour window. Prevalence is high, and most people with chronic infection are unaware of it, which is why screening campaigns matter as much as vaccination.

Key points

PrevalenceHigh, among the largest burdens worldwide
VaccinationPart of routine immunisation, in the combined vaccine
Birth doseNational policy, but coverage is far below that of later doses
Home birthsThe main reason the birth dose is missed
Antenatal screeningIncreasingly offered, not yet universal
TreatmentAvailable, usually at the patient's own cost
Blood safetyScreening of donated blood is mandatory

In practice

Cost and coverage

Vaccination through routine immunisation is free; testing and treatment usually are not.

Where to go

Worth knowing

The cost of treatment, not its availability, is the binding constraint. Monitoring is far cheaper than treatment and still valuable: it identifies who genuinely needs medication and when.

Frequently asked questions

How do you get tested in Nigeria?

A rapid test at a hospital, laboratory or during a screening campaign gives a result the same day, and a positive result should be confirmed and followed by assessment of liver health. Testing is inexpensive, and many campaigns offer it free.

Why does the birth dose matter so much?

Because transmission from mother to baby at birth is the route most likely to produce a lifelong chronic infection — an infant infected at birth has a very high chance of never clearing the virus, whereas an adult usually does. A vaccine dose within twenty-four hours of birth, with immunoglobulin where the mother is positive, prevents this in the great majority of cases.

Official sources and links

← All countries Hepatitis B →

Page checked in September 2026. The instruments cited can change: if in doubt, confirm with the official source given.

Locate this page in the site map

A question, a correction, a suggestion? Write to us.